Axid®
|
Available as: Capsule 150mg 300mg SPC |
Product type: H2 Blocker Available: Ireland , UK For the treatment of the following diseases where reduction of gastric acid is indicated: Duodenal ulcer Benign gastric ulcer Prevention of duodenal or benign gastric ulcer recurrence Gastric oesophageal reflux disease (including erosions, ulcerations and associated heartburn) Gastric and/or duodenal ulcer associated with concomitant use of non-steroidal anti-inflammatory drugs |
Flynn has entered an agreement with MicroPharm to distribute its European Viper anti-venom
Flynn Pharma has been appointed distributor for Circadin in UK and Ireland
Clostridium difficile
download a free training presentation (Either click the link to view, or right click and select 'save target as' for saving to your computer)